Benefit Risk contextualisation of COVID-19 vaccines in the EU

First published 24/11/2021

Last updated 23/04/2024

EU PAS number:

EUPAS44229

Study

Finalised

Documents

Study protocol

Initial protocol

COVID 19 risk benefit analysis for EMA- study protocol

English (484.14 KB - PDF) View document

Updated protocol

Study protocol EUPAS44229

First published: 22/02/2024

English (486.36 KB - PDF) View document

Study results

EMA_COVID19_vaccines_final_report_20042022

English (5.55 MB - PDF) View document

Study report

Other information

Secondary tabs